Showing results (161-170 of 650) with videos related to
Sort By:
Pageof 65
PPAR Research|January 28, 2021
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental EffectsFabiola Cortes-Lopez, Alicia Sanchez-Mendoza, David Centurion, et al.PPAR Research|September 10, 2011
Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid OxidationJian Liu, Peiyong Wang, Lan He, et al.PPAR Research|March 27, 2012
Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injuryBoris Betz, Reinhard Schneider, Tobias Kress, et al.PPAR Research|March 27, 2012
The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer CellsAdrienne Bolden, Lynikka Bernard, Danielle Jones, et al.PPAR Research|March 26, 2011
The Peroxisomal 3-keto-acyl-CoA thiolase B Gene Expression Is under the Dual Control of PPARα and HNF4α in the LiverJ Chamouton, F Hansmannel, J A Bonzo, et al.PPAR Research|April 5, 2011
Isoflavones and PPAR Signaling: A Critical Target in Cardiovascular, Metastatic, and Metabolic DiseaseRakesh P Patel, Stephen BarnesPPAR Research|December 3, 2011
Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory ProcessesCaroline I Schnegg, Mike E RobbinsPPAR Research|December 23, 2011
Skeletal effects of the saturated 3-thia Fatty Acid tetradecylthioacetic Acid in ratsAstrid Kamilla Stunes, Irene Westbroek, Reidar Fossmark, et al.PPAR Research|May 1, 2009
MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activationApurva Chandalia, Holly J Clarke, L Edward Clemens, et al.Pageof 65